Pulmonary vein isolation by means of a novel cryoballoon technology in paroxysmal atrial fibrillation patients: 1 ‐year outcome from a large Italian multicenter clinical registry

ConclusionThe novel POLARx cryo-balloon system is safe and effective for PV isolation, displaying a 1-year freedom from atrial arrhythmia recurrence of 86.4%, which is in line to that reported with AFA-Pro CB or RF ablation.Clinical trial registrationCatheter Ablation of Arrhythmias with a High-Density Mapping System in Real-World Practice (CHARISMA). URL:http://clinicaltrials.gov/ Identifier: NCT03793998. Registration date: January 4, 2019.

Source: Pacing and Clinical Electrophysiology : PACE - October 17, 2023 Category: Cardiology Authors: Stefano Bianchi, Antonio De Simone, Saverio Iacopino, Gaetano Fassini, Maurizio Malacrida, Pietro Rossi, Giuseppe Stabile, Andrea Petretta, Fabrizio Tundo, Filippo Maria Cauti, Sara Iuliano, Pasquale Filannino, Massimo Moltrasio, Michela Morl Tags: ELECTROPHYSIOLOGY Source Type: research